ACB-1801

N/A

Report date: 2024/06/26 15:58:26
NME

Base Information

Drug NameACB-1801
Drug Alias NameACB-1801
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActin modulatorsDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors
TargetsActinDual-specificity tyrosine-phosphorylation regulated kinase 1A
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAC BioScience SAAC Biotech
China Registration ClassN/A

Develop Information

Active CompaniesAC BiotechAC BioScience SA
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A